Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Nov 28, 2016; 22(44): 9803-9812
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9803
Table 3 Correlation of fibroblast growth factor receptor 1 and MYC amplification status between the tumors of the primary and the metastatic lymph nodes, n (%)
Metastatic lymph nodes
TotalP value
No amplificationAmplification
FGFR1 Primary tumorNo amplification42 (91.3)3 (6.7)45 (100)< 0.001
Amplification4 (36.4)7 (63.6)11 (100)
Total46 (82.1)10 (17.9)56 (100)
MYC Primary tumorNo amplification17 (63.0)10 (37.0)27 (100)1.000
Amplification12 (60.0)8 (40.0)20 (100)
Total29 (61.7)18 (38.3)47 (100)